000 | 01986 a2200589 4500 | ||
---|---|---|---|
005 | 20250515220829.0 | ||
264 | 0 | _c20100713 | |
008 | 201007s 0 0 eng d | ||
022 | _a1534-6080 | ||
024 | 7 |
_a10.1097/TP.0b013e3181db09e4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGlotz, Denis | |
245 | 0 | 0 |
_aThymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids. _h[electronic resource] |
260 |
_bTransplantation _cJun 2010 |
||
300 |
_a1511-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xmetabolism |
650 | 0 | 4 |
_aAntilymphocyte Serum _xchemistry |
650 | 0 | 4 |
_aCalcineurin _xchemistry |
650 | 0 | 4 | _aCalcineurin Inhibitors |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGlomerular Filtration Rate |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aKidney Transplantation _xmethods |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMycophenolic Acid _xanalogs & derivatives |
650 | 0 | 4 |
_aSirolimus _xtherapeutic use |
650 | 0 | 4 |
_aSteroids _xtherapeutic use |
650 | 0 | 4 |
_aTacrolimus _xtherapeutic use |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aCharpentier, Bernard | |
700 | 1 | _aAbramovicz, Daniel | |
700 | 1 | _aLang, Philippe | |
700 | 1 | _aRostaing, Lionel | |
700 | 1 | _aRifle, Gerard | |
700 | 1 | _aVanrenterghem, Yves | |
700 | 1 | _aBerthoux, Francois | |
700 | 1 | _aBourbigot, Bernard | |
700 | 1 | _aDelahousse, Michel | |
700 | 1 | _aChalopin, Jean-Marc | |
700 | 1 | _aCassuto, Elisabeth | |
700 | 1 | _aLefrançois, Nicole | |
773 | 0 |
_tTransplantation _gvol. 89 _gno. 12 _gp. 1511-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/TP.0b013e3181db09e4 _zAvailable from publisher's website |
999 |
_c19745096 _d19745096 |